Figure 1From: DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer DEK is overexpressed in CRC. Western blot analysis of a panel of human derived colorectal cancer cell lines showed higher DEK expression than human non-tumor mucosa tissues (NT1, NT2).Back to article page